A Randomised Trial Comparing Trastuzumab Deruxtecan to CDK4/6 Inhibitors in Non-luminal A, ER-positive/HER2-low Metastatic Breast Cancer

Clinical trial NCT06585969 · WITHDRAWN

Trial details

NCT number: NCT06585969
Sponsor: Danish Breast Cancer Cooperative Group
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Breast Cancer ER-positive Breast Cancer Luminal B Her2 Enriched Basal Like

Start date: 2026-01-01
Primary completion: 2026-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.